Clinical Trial Update: Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pomalidomide in patients with fibrotic-stage myeloproliferative neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

Sponsor: University of Ulm | Conditions: Myeloproliferative Neoplasms | Phase 2 | Status: COMPLETED